Association between antidiabetic drugs and psoriasis risk in diabetic patients: Results from a nationwide nested case-control study in Taiwan

Journal of the American Academy of Dermatology

Volumn 72, Issue 1, 2015, Pages 123-130

  Wu, Chun Ying ^a,b,d,e   Shieh, Jeng Jer ^b,e   Shen, Jui Lung ^c,f   Liu, Yi Ya ^b   Chang, Yun Ting ^a,c   Chen, Yi Ju ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^f FENG CHIA UNIVERSITY   (Taiwan)

Author keywords

diabetes mellitus; insulin; metformin; psoriasis; thiazolidinedione

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN; MEGLITINIDE; METFORMIN; SULFONYLUREA;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; FOLLOW UP; HEALTH INSURANCE; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIFESTYLE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PSORIASIS; ADOLESCENT; AGED; CHEMICALLY INDUCED; CHILD; DRUG ERUPTIONS; INFANT; MIDDLE AGED; PRESCHOOL CHILD; RISK ASSESSMENT; TAIWAN; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS; DRUG ERUPTIONS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; MALE; MIDDLE AGED; PSORIASIS; RISK ASSESSMENT; TAIWAN; YOUNG ADULT;

EID: 84916931966     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.08.042     Document Type: Article

References (39)

1. A.W. Armstrong, C.T. Harskamp, and E.J. Armstrong Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis JAMA Dermatol 149 2013 84 91
2. U. Khalid, P.R. Hansen, G.H. Gislason, J. Lindhardsen, S.L. Kristensen, and S.A. Winther Psoriasis and new-onset diabetes mellitus: a Danish nationwide cohort study Diabetes Care 36 2013 2402 2407
3. M.S. Lee, R.Y. Lin, and M.S. Lai Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study J Am Acad Dermatol 70 2014 691 698
4. W. Sterry, B.E. Strober, and A. Menter International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review Br J Dermatol 157 2007 649 655
5. T. Henseler, and E. Christophers Disease concomitance in psoriasis J Am Acad Dermatol 32 1995 982 986
6. L. Naldi, L. Chatenoud, D. Linder, A. Belloni Fortina, A. Peserico, and A.R. Virgili Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study J Invest Dermatol 125 2005 61 67
7. A.L. Neimann, D.B. Shin, X. Wang, D.J. Margolis, A.B. Troxel, and J.M. Gelfand Prevalence of cardiovascular risk factors in patients with psoriasis J Am Acad Dermatol 55 2006 829 835
8. D. Kirpichnikov, S.I. McFarlane, and J.R. Sowers Metformin: an update Ann Intern Med 137 2002 25 33
9. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli Cellular and molecular mechanisms of metformin: an overview Clin Sci (Lond) 122 2012 253 270
10. B. Viollet, R. Mounier, J. Leclerc, A. Yazigi, M. Foretz, and F. Andreelli Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders Diabetes Metab 33 2007 395 402
11. E. Morikang, S.C. Benson, T.W. Kurtz, and H.A. Pershadsingh Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes Am J Hypertens 10 1997 440 446
12. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
13. H. Yki-Jarvinen Thiazolidinediones N Engl J Med 351 2004 1106 1118
14. R.A. Hegazy, R.M. Abdel Hay, O. Shaker, S.S. Sayed, and D.A. Abdel Halim Psoriasis and metabolic syndrome: is peroxisome proliferator-activated receptor-gamma part of the missing link? Eur J Dermatol 22 2012 622 628
15. F. Babad Psoriasis and phenformin hydrochloride: a report on 2 cases J Med Soc N J 71 1974 412
16. R. Koca, H.C. Altinyazar, S. Yenidunya, and N.S. Tekin Psoriasiform drug eruption associated with metformin hydrochloride: a case report Dermatol Online J 9 2003 11
17. Y.B. Brauchli, S.S. Jick, F. Curtin, and C.R. Meier Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case-control study J Am Acad Dermatol 58 2008 421 429
18. N. Shafiq, S. Malhotra, P. Pandhi, M. Gupta, B. Kumar, and K. Sandhu Pilot trial: pioglitazone versus placebo in patients with plaque psoriasis (the P6) Int J Dermatol 44 2005 328 333
19. R. Mittal, S. Malhotra, P. Pandhi, I. Kaur, and S. Dogra Efficacy and safety of combination acitretin and pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial Arch Dermatol 145 2009 387 393
20. A. Malhotra, N. Shafiq, S. Rajagopalan, S. Dogra, and S. Malhotra Thiazolidinediones for plaque psoriasis: a systematic review and meta-analysis Evid Based Med 17 2012 171 176
21. Y.J. Chang, M.L. Yeh, Y.C. Li, C.Y. Hsu, Y.T. Yen, and P.Y. Wang Potential drug interactions in dermatologic outpatient prescriptions-experience from nationwide population-based study in Taiwan Dermatol Sin 29 2011 81 85
22. Y.T. Chang, T.J. Chen, P.C. Liu, Y.C. Chen, Y.J. Chen, and Y.L. Huang Epidemiological study of psoriasis in the national health insurance database in Taiwan Acta Derm Venereol 89 2009 262 266
23. C.Y. Wu, Y.J. Chen, H.J. Ho, Y.C. Hsu, K.N. Kuo, and M.S. Wu Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection JAMA 308 2012 1906 1914
24. Y.J. Chen, C.Y. Wu, J.L. Shen, T.T. Chen, and Y.T. Chang Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan J Am Acad Dermatol 69 2013 25 33
25. C.S. Gau, I.S. Chang, F.L. Lin Wu, H.T. Yu, Y.W. Huang, and C.L. Chi Usage of the claim database of national health insurance program for analysis of cisapride-erythromycin co-medication in Taiwan Pharmacoepidemiol Drug Saf 16 2007 86 95
26. V. Essebag, R.W. Platt, M. Abrahamowicz, and L. Pilote Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure BMC Med Res Methodol 5 2005 5
27. P.K. Ruan, and R.J. Gray Analyses of cumulative incidence functions via non-parametric multiple imputation Stat Med 27 2008 5709 5724
28. P. Kumar, K. Natarajan, and N. Shanmugam High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression Cell Signal 26 2014 528 539
29. E. Dalmas, N. Venteclef, C. Caer, C. Poitou, I. Cremer, and J. Aron-Winewsky T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes Diabetes 63 2014 1966 1977
30. A.F. Moore, T. Soper, N. Jones, J. Grevelink, and N. Abourizk Psoriatic exacerbation associated with insulin therapy Diabetes Care 31 2008 e31
31. S. Field, G. Kelly, A.M. Tobin, J.M. Barragry, K.C. Conlon, and B. Kirby Severe deterioration of psoriasis due to an insulinoma Clin Exp Dermatol 33 2008 145 147
32. P. Wang, and Y. Ran Subcutaneous injection of isophane protamine biosynthetic human insulin induced psoriasis at the injection site Eur J Dermatol 21 2011 807 808
33. C. Hyde, B. Hollier, A. Anderson, D. Harkin, and Z. Upton Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration J Invest Dermatol 122 2004 1198 1206
34. O. Pirgon, M.E. Atabek, and A. Sert Psoriasis following growth hormone therapy in a child Ann Pharmacother 41 2007 157 160
35. A. Bai, A.G. Ma, M. Yong, C.R. Weiss, Y. Ma, and Q. Guan AMPK agonist down-regulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis Biochem Pharmacol 80 2010 1708 1717
36. N. Nath, M. Khan, M.K. Paintlia, I. Singh, M.N. Hoda, and S. Giri Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis J Immunol 182 2009 8005 8014
37. C.S. Park, B.R. Bang, H.S. Kwon, K.A. Moon, T.B. Kim, and K.Y. Lee Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase Biochem Pharmacol 84 2012 1660 1670
38. J. Suzuki, T. Yoshimura, M. Simeonova, K. Takeuchi, Y. Murakami, and Y. Morizane Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis Invest Ophthalmol Vis Sci 53 2012 4158 4169
39. H. Glossmann, and N. Reider A marriage of two "Methusalem" drugs for the treatment of psoriasis? Arguments for a pilot trial with metformin as add-on for methotrexate Dermatoendocrinol 5 2013 252 263